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POSTER SESSION 1041-16 Sex Difference and Heart Rate Dependence of 
Transmural Heterogenity of Repolarization 
Peter Sri~etana, Velislav N. Batchvarov. Katerina Hnatkova, Marek Malik, St. George’s 
Hospital Medical School, London, United Kingdom 
Background: The interval from the peak to the end of the T wave (TpTe) is considered 
to reflect transmural repolarisation heterogeneity (TRH). Several studies have previously 
described TpTe to be independent of heart rate, which contradicts the in-vitro observa- 
tion of marked changes I” TRH due to cycle length changes. We therefore investigated 
relationship of TpTe to heart rate I” healthy young women (n=22, 28* 6 years) and men 
(n=20, 26* 6 years). 
Methods: During 24-h recordings (SEER MC Marquette), a 10.set 12-lead ECG was 
obtained every 30 sec. Recordings were repeated after 1 d, 1 w, and 1 m and results 
pooled together in each subject. The QT and QTpeak (QTp) intervals were obtained 
automatically using QT Guard software (Marquette) and TpTe was computed es the dif- 
ference QT-QTp. In each subject TpTe values were averaged over 10 ms RR interval 
bins from 550 to 1150 ms. 
Results: In both sexes TpTe interval showed marked rate dependence with prolongation 
at long RR intervals. TpTe intervals in men (circles) were significantly longer over the 
entire range of investigated RR intervals (p&8x 1Cf46). However, whereas the differ- 
ence between sexes was marked at short cycle length (550 ms: women 67+ 4, men 96+ 
7, p= 5x 1O-5) it decreased at long cycle lengths (1150 ms: women lOO+ 4, men 106* 6. 
p=3x 10.3). 
Conclusions: There is a marked rate dependence of TpTe interval which differs 
between women and men. The rate dependent increase in TRH in women might be one 
of the reasons for the increased propensity of torsades de pointes in women. 
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1041-17 Beat-To-Beat Variability Is an Independent and Early 
Indicator for d-Sotalol-Induced Arrhythmias In Vivo 
Marten Thomsen, Cora Verduyn, Milan Stengl, Jurren M. Van Opstal. Jet Leunissen, 
Geert de Pater, Paul G. Volders. Marc A. Vos, Cardiovascular Research Institute 
Maastricht, Maastricht, The Netherlands 
Background: Beat-to-beat variability of repolarization (BVR) has been associated with 
sudden cardiac death in patients and with drug-induced proarrhythmia in isolated rabbit 
hearts. This study tried to relate repolarization parameters, including BVR. to drug 
induced torsades de pointes (TdP) arrhythmias in dogs. 
Methods: 2 and 4 “g/kg d-Sotalol (dS) were administered in a random crossover design 
to 8 anesthetized dogs with chronic AV block. Endocardial MAP durations (MAPD) from 
both ventricles (LV and RV) and surface EGG were recorded; Interventricular dispersion 
(LV - RV MAPD) and extrasystolic (ES) frequency were calculated. BVR was quantified 
by the area of the Pomcar~ plots (figure) for LV, RV MAPD and QT during 30.beat peri- 
ods at baseline (BL) and in the presence of dS just prior to extrasystolic activity preced- 
ing TdP. 
Results: The repolarization parameters (QT, LV, RV MAPD and dispersion) could not 
account for the difference in TdP occurrence (218 vs. 618 after 2 and 4 mglkg dS, respec- 
tively). In contrast, the LV Potncare plot area and the frequency of multiple extrasystoles 
.(mES) were higher in the 4 mglkg group. BVR was present before ES occurred and inde- 
pendent of the other repolarization parameters. 
Conclusions: Where the QT-duration and the other repolarization parameters failed, 
beat-to-beat variability of the LV and the frequency of “ES corresponded with the dose- 
dependent TdP induction. BVR is an Independent and early measurement that could 
become important in predicting drug-induced TdP. 
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1042 Beyond Radio Frequency: New Ablation 
Techniques 
Sunday, March 30, 2003, Noon-2:00 p.m. 
McCormick Place, Hall A 
Presentation Hour: 1:OO p.m.-2:OO p.m. 
1042-l Treatment of Supraventricular Tachyarrhythmias With 
the CryoCor Cryoablation System: Worldwide Results 
Luz-Maria Rodriauez, J. Christoph Geller, Hung-Fat Tse, Carl Timmermans, Sven Reek, 
Kathy La&Fun Lee, Gregory M. Ayers, Chu-Pak Lau, Helmut U. Klein, Harry J. Crijns, 
Academic Hospital Maastricht and Cardiovascular Research Institute, Maastricht, The 
Netherlands 
Background: Cryoablation has been used during cardiac surgery for the treatment of 
arrhythmias. Recently, with the advent of newer cryogenics technology, it has been pos- 
sible to develop endocardial catheters that deliver this form of thermal energy. Methods: 
There were 103 pts enrolled at four clinical sites in this multi-center trial. Of these pts, 43 
had atrial fibrillation (AF) and were treated with the CryoCorTM Cryoablation System 
(CryoCor, Inc.) to electrically isolate the pulmonary veins using segmental ablation 
(PVA), while 60 pts had ablation targets that included right atrial sites (RSA) and were 
treated wfth ablation using conventional approaches dependent on the arrhythmia. Of the 
RSA pts, 43 had atrial flutter, 6 had Wolff-Parkinson-White syndrome, 7 had atrioventrlc- 
ular nodal reentry tachycardla, 2 had a right atrial tachycardia, and 2 pts underwent atri- 
oventricular junctional ablation for permanent AF. There were 78 males and 25 females 
enrolled, with the mean age 51 f 13 years. 
Results: There was 98% acute efficacy for all pts (98% for PVA and RSA as individual 
groups). With a mean of 8 months follow-up, 78% of PVA pts showed improvement after 
cryoablation, with 52% having no AF episodes documented on transtelephonic monitor- 
ing. Forty-two (42) of the 60 RSA pts have reached 3-month follow-up with a chronic sue- 
cess rate of 98% (2 pts had recurrence, 1 right lateral WPW. 1 right-sided AF). Both pts 
were retreated with cryoablation and at 3 month follow-up were without recurrence. Two 
pts in the RSA developed a new arrhythmia, AF in both cases. There were 6 serious 
adverse events that occurred in 3 pts who were treated with PVA and 3 pts treated with 
RSA (three pulmonary embolic events [one PVA and two RSA], a stroke, an AV fistula in 
the groin, and syncope). Comparison of spiral CT scans done at baseline with those at 3 
months showed no stenosis in the PVA group. 
Conclusion: Cardiac cryoablation is safe and effective for the treatment of supraventric- 
ular tachyarrhythmias in man. 
1042-2 Randomized Study Comparing Radiofrequency Ablation 
With Cryoablation for the Treatment of Atrial Flutter 
Carl TimmermanS Suzanne Philippens. Randy Manusama, Harry H. Crijns, Luz-Maria 
Rodriguez, Academic Hospital Maastricht.. Maastricht, The Netherlands 
Background: Radiofrequency ablation (RF) of type I atrial flutter (AFL) has a high proce- 
dural success rate (96%) and low recurrence rate (6.9%). However, RF of the cavotricus- 
pid isthmus (CTI) can be painful. The aim of this study was to compare the efficacy and 
procedural pain of RF with cryoablation (ctyo) for the treatment of AFL. 
Methods: Fourteen patients (55 + 11 years, 11 men) with AFL were randomized either to 
RF (n=7) or cryo (n=7) of the CTI using point-by-point applications. Cryo was performed 
with the CryoCorTM cryoablation system. Cryothermia was delivered twice, for 4 minutes, 
at each site along the CTI. RF was performed with a E-mm tip catheter. RF applications 
were given during 90 s with a preset temperature of 70°C and a power limit of 50 W. Pain 
was evaluated after every application using a visual analogue scale (VAS) ranging from 0 
to 100. Endocardial electrograms, indicating ablation-catheter tip position along the CTI, 
were correlated with pain perception. 
Results: In the cry0 group, all patients were successfully ablated at a mean of 9 sites 
(mean 18 applications) along the CTI with nadir temperatures between -69 and -89°C 
(mean -81.4 * 4.8”C). In the RF group, all but one patient were successfully ablated with 
a mean of 13 f 11 applications. Left atrlal size, type of AFL, presence of concomttant 
atrial fibrillation, number of applications, fluoroscopic and procedure time did not differ 
between both groups (p>O.O5). Patients of the cryo group perceived significantly less 
pain during the applications compared to patients of the RF group (mean VAS = 0.4 * 2.7 
versus 24 zt 28, p = 0.04). In the RF group 57/94 (61%) and I” the cryo group 3/125 (2%) 
applications were painful. All patients of the RF group perceived pain, mainly dunng abla- 
tion in the right atrium or at the right atrium-inferior vene cava transition (p<O.O5). After a 
mean follow-up of 4.3 r 2.1 months no recurrences of AFL occurred. 
Conclusions: The success rate obtained with cryo of the CTI for AFL is at least as high 
as that seen with RF ablation. Furthermore, cryo of the CTI is painless. 
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